A phase I/II study of MCS110 with BRAF/MEK inhibition in patients with melanoma after progression on BRAF/MEK inhibition
In: Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies, Jg. 41 (2023-06-01), Heft 3, S. 365-370
Online
academicJournal
Zugriff:
Titel: |
A phase I/II study of MCS110 with BRAF/MEK inhibition in patients with melanoma after progression on BRAF/MEK inhibition
|
---|---|
Autor/in / Beteiligte Person: | Buchbinder, Elizabeth I. ; Giobbie-Hurder, Anita ; Ott, Patrick A. |
Link: | |
Zeitschrift: | Investigational New Drugs: Novel Anti-Cancer Therapeutics and Therapies, Jg. 41 (2023-06-01), Heft 3, S. 365-370 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 0167-6997 (print) ; 1573-0646 (print) |
DOI: | 10.1007/s10637-023-01364-5 |
Sonstiges: |
|